Raina Moskowitz appointed as director.

✦Match Group appointed Raina Moskowitz as a director, expanding its board composition and potentially bringing new expertise to oversight of the dating and social platform company.

👤 Raina Moskowitz — Raina Moskowitz currently serves as CEO of The Knot Worldwide, a global technology platform powering celebrations. Prior to joining in 2025, she served as Etsy's Chief Operating and Marketing Officer, where she oversaw company strategy and operations, with Etsy's Gross Merchandise Volume tripling during her tenure. Before Etsy, Moskowitz led U.S. consumer marketing at American Express, where she was responsible for driving growth and retention across its consumer product portfolio.

On April 26, 2026, FDEE Consulting, Inc., a wholly owned subsidiary of Fluor Corporation (the "Corporation"), entered into a Consulting Agreement (the Consulting Agreement ) with Mr. Fields, the Corporation s former Group President, Strategic Projects, pursuant to which Mr.

✦Fluor Corporation retained its former Group President for Strategic Projects as a consultant through subsidiary FDEE Consulting, suggesting continuity on complex project initiatives.

The RSUs were granted under the Company s existing 2023 Equity Incentive Plan. 50% of the RSUs will vest as follows: 1/3 on December 15, 2026, 1/3 December 15, 2027, and 1/3 December 15, 2028.

✦Vuzix Corporation granted RSUs to executives with staggered vesting through 2028, aligning long-term compensation with company performance and reducing near-term dilution concerns for shareholders.

✦Coeptis Therapeutics completed its acquisition of Anchorag on April 24, 2026, expanding its therapeutic portfolio and potentially enhancing revenue streams for shareholders.

Doug Evan appointed as independent director. Joseph Capper appointed as independent director.

✦TELA Bio appointed Doug Evan and Joseph Capper as independent directors, strengthening board governance and potentially signaling confidence in the company's strategic direction.

👤 Doug Evan — Joseph Capper is a highly experienced healthcare executive with nearly 30 years in MedTech and Life Sciences leadership, currently serving as CEO of MiMedx Group Inc. since January 2023 and previously as CEO of BioTelemetry, Inc. from 2010 to 2021, where he led a significant turnaround culminating in the company's $2.8 billion acquisition by Royal Philips. Earlier in his career, he held President and CEO roles at Home Diagnostics and CCS Medical, spent a decade in various leadership positions at Bayer AG, and served as a naval aviator in the U.S. Navy.

Ian Blackman appointed as Chief Financial Officer. effective April 27, 2026.

✦Nexgel appoints Ian Blackman as Chief Financial Officer effective April 27, 2026, signaling potential strategic shifts in financial management and governance that investors should monitor.

👤 Ian Blackman — Ian Blackman, age 58, is a CPA with over 30 years of global financial leadership experience who most recently served as Chief Financial Officer of McIntosh Group Inc. (Bose Luxury) from 2018 to 2025, where he led financial operations for a private equity-backed luxury consumer electronics company and was involved in multiple transaction processes. Prior to that, he held the position of CFO, North America for Diptyque and Byredo luxury brands, and spent 16 years at Universal Music Group in roles of increasing responsibility, beginning his career as an Audit Manager at Goldstein Golub Kessler and Company from 1989 to 1995.

On April 24, 2026, the Compensation Committee ( Committee ) of the Board of Directors (the Board ) of TechTarget, Inc. The GAP provides certain key executives and senior leaders of the Company (the Covered Executives ) with the opportunity to earn cash bonus payments at the end of a specified performance period based on the attainment of various performance targets that may be based on earnings per share, revenues, operating profit, CAGR, EBIT, Adjusted EBITDA, or such other metrics as the Commi

✦TechTarget's Compensation Committee approved a performance-based cash bonus plan for key executives tied to metrics including earnings, revenue, and EBITDA, potentially affecting executive compensation costs and shareholder value alignment.

Gary Kolstad appointed as independent director.

✦RPC, Inc. strengthens its board governance by appointing Gary Kolstad as an independent director, enhancing oversight and bringing external expertise to the oilfield services company.

👤 Gary Kolstad — Gary Kolstad had a long career in various oilfield services positions at a large, international oil and gas services company, before serving as Chairman and CEO of public and private companies, and currently holds multiple Advisory Board Member and Investor positions. He holds a B.S. degree from Montana Technological University in petroleum engineering and studied Psychology and Engineering at Montana State University-Bozeman.

Kuechen will continue with the Company in the position of Head of Mergers and Acquisitions.

✦Cognex Corporation reassigned executive Kuechen to head its Mergers and Acquisitions department, signaling potential strategic growth through acquisitions or corporate partnerships.

Christopher Gibson appointed as director. Christopher Gibson will not stand for re-election.

✦Recursion Pharmaceuticals appoints Christopher Gibson as director while he simultaneously declines re-election, suggesting a transitional leadership change with unclear long-term implications.

👤 Christopher Gibson — Based on the search results, Christopher Gibson was not recently appointed as director at Recursion Pharmaceuticals. Rather, he was transitioning from CEO to Chairman of the Board in November 2025 . Regarding his career history: Gibson developed Recursion's foundational technology during his MD/PhD work in Dr. Dean Li's lab at the University of Utah, then left medical school to build the company . He is a Rice University graduate with degrees in bioengineering and management , and currently serves on the Board of Directors at PacBio .

Jim S. Holotik appointed as director.

✦USA Compression Partners appointed Jim S. Holotik as director, expanding board oversight of the midstream energy partnership's operations and strategic decisions.

👤 Jim S. Holotik — Jim S. Holotik has more than 30 years of exploration and pipeline experience , with prior roles including President at Transwestern Pipeline Co. LLC, Commercial Vice President-Project Development at ETP Legacy LP, Executive Vice President at Cornerstone Natural Gas, Inc., and Director-East & West Regions at El Paso Field Services Co. At Energy Transfer Partners, he was responsible for leading merger and acquisition efforts before transitioning to executive positions in the energy midstream sector.

On April 30, 2026 (the Effective Date ), the Board of Directors (the Board ) of GEN Restaurant Group, Inc. In connection with this change, on April 29, 2026, Messrs.

✦GEN Restaurant Group's board executed an executive leadership change on April 30, 2026, with unnamed executives departing, signaling potential strategic repositioning that investors should monitor for impact on operations.

Gramz informed The Marcus Corporation (the Company ) of his intent to retire as the President of Marcus Theatres, effective as of March 31, 2026. Subsequently, on April 7, 2026, the Company announced that Mr.

✦Marcus Theatres President Gramz is retiring effective March 31, 2026, signaling potential leadership transition and strategic direction changes for The Marcus Corporation's theater operations.

Gunnar Wiedenfels resigned as director.

✦Warner Bros. Discovery lost director Gunnar Wiedenfels through resignation, which may signal internal governance changes and could affect board oversight of the media and entertainment company.

Appointment of Chief Financial Officer On April 30, 2026, Eos Energy Enterprises, Inc. ( Eos and, together with its subsidiaries, the Company ) announced that, effective June 8, 2026, Alessandro Lagi will be the new Chief Financial Officer of the Company.

✦Eos Energy Enterprises appointed Alessandro Lagi as Chief Financial Officer effective June 8, 2026, signaling leadership transition in financial management at the energy storage company.

RLJ Lodging Trust 2026 Equity Incentive Plan As described below in

✦RLJ Lodging Trust's executive compensation structure is being updated through a new 2026 Equity Incentive Plan, affecting stock-based awards and potential dilution for shareholders.

Sukhi Nagesh resigned as director.

✦Entegris Inc (ENTG) lost director Sukhi Nagesh through resignation, potentially affecting board composition and governance oversight at the materials science company.

Robert L. Masson appointed as Interim Chief Financial Officer. effective April 29, 2026.

✦Fermi Inc. appointed Robert L. Masson as Interim CFO effective April 29, 2026, signaling potential leadership transition in financial management that investors should monitor for strategic implications.

👤 Robert L. Masson — Robert L. Masson brings over 20 years of finance executive experience across aerospace, defense, and industrial sectors, most recently serving as Chief Financial Officer of Noble Supply and Logistics (2023-2025) and previously as CFO of Latham Group (2022-2023) and Hypertherm (2018-2022). He also held Vice President of Finance at Flowserve (2016-2018) and served in various finance leadership roles at Raytheon Technologies (2003-2016), including CFO positions for multiple business units. Mr. Masson began his career as a Lieutenant and Naval Aviator in the U.S. Navy (1992-2001) and holds a Bachelor of Science in Economics from the U.S. Naval Academy and an MBA from Harvard Business School.

Marlie Davis appointed as Chief Financial Officer. effective May 1, 2026.

✦Marlie Davis was appointed Chief Financial Officer of Regional Health Properties Inc effective May 1, 2026, signaling potential leadership changes in financial management.

👤 Marlie Davis — Marlie Davis, age 55, is a CPA with more than 20 years of finance, accounting, audit, and real estate investment experience, having served as Chief Financial Officer and Controller of Hatteras Sky since 2019 where she led finance and accounting operations for a multi-entity real estate investment platform. Earlier in her career, she held senior finance and assurance roles at Sixty West, Cherry Bekaert LLP, AGH, LLC, and CohnReznick LLP, focusing on financial reporting, audit, internal controls, and advisory services for public companies, real estate developers, and investment entities. Ms. Davis holds an MBA from Utica College and a BBA in Accounting from the University of Central Florida.

On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the Company ) of his intention to retire as the Company s Chief Financial Officer. McClurg s retirement as Chief Financial Officer will be June 30, 2026.

✦NeuroOne Medical Technologies' CFO Ronald McClurg will retire June 30, 2026, creating potential leadership uncertainty during a critical financial oversight period.

(e) below, on April 29, 2026, the Company executed Term Sheets for the employment of certain key employees ( Key Employees ), to be effective at Closing). The consummation of the Merger and Internalization is also subject to certain closing conditions, including, among other conditions, (i) the continued accuracy of the parties representations and warranties, (ii) shareholder approval of the Stock Issuance, and the listing of the shares on the NYSE, (iii) execution of employment agreements with

✦ACRES Commercial Realty Corp. secured employment term sheets with key executives effective upon closing of its planned merger and internalization, contingent on shareholder approval and NYSE listing.

Bart Bedard appointed as Officer. William F. Greene resigned as Chief Financial Officer. Bart Bedard resigned as director. effective April 27, 2026.

✦Moving iMage Technologies replaced its CFO William F. Greene with officer Bart Bedard, who simultaneously resigned from the board, indicating potential leadership instability at the company.

👤 Bart Bedard — Bart Bedard brings over 30 years of US and international financial and accounting leadership experience, having held CFO and senior finance positions with a strong track record in supporting strategic growth and implementing efficiency and cost reduction initiatives. He began his career in Corporate Controller and Director of Finance roles at subsidiaries of Goodrich and L-3 Harris Technologies, and since 2021 has served as a financial consultant for several private equity-backed companies supporting audits, financial reporting, compliance, and internal controls. Bedard holds a BA in Accounting from Brigham Young University, an MBA from California State University, Fullerton, and a Certified Public Accounting license.

Brian Herb resigned as Executive Vice President. effective May 25, 2026.

✦CCC Intelligent Solutions' Executive Vice President Brian Herb is departing, effective May 25, 2026, marking a leadership change that investors should monitor for potential strategic implications.